LS ARK Genomic Revolution Tracker ETP Securities XS2399368062
2.36
EUR
-0.01
EUR
-0.43 %
09:05:06
NAV
| Kurse | Charts | Stammdaten | Kennzahlen | Aktion |
|---|---|---|---|---|
| Snapshot | Preischart | Daten + Gebühr | Performance | Portfolio |
| Börsenplätze | Performance | Management | Volatilität | Watchlist |
| Historisch | Benchmark | Sharpe Ratio | ||
| Rendite | Ratings |
Kurse
Charts
Stammdaten
Kennzahlen
Nettoinventarwert (NAV)
| 2.68 USD | -0.06 USD | -2.12 % |
|---|
| Vortag | 2.73 USD | Datum | 10.06.2026 |
LS ARK Genomic Revolution Tracker ETP Securities Kurs - 1 Jahr
Anzeige
Top Kryptowährungen ETPs
| Name | ISIN | Performance | |
|---|---|---|---|
| 21Shares Injective Staking ETP | CH1360612134 | 68.73% | |
| 21shares Hyperliquid Staking ETP | CH1471826029 | 64.32% | |
| 21Shares NEAR Protocol Staking ETP | CH1162108893 | 53.81% | |
| 21Shares Ondo ETP | CH1396389921 | 34.55% | |
| 21Shares Toncoin Staking ETP | CH1297762812 | 33.73% | |
| 21Shares Stellar ETP | CH1109575535 | 17.06% | |
| 21Shares Jupiter ETP | CH1480821383 | 0.52% | |
| 21shares Strategy Yield ETP USD | CH1528107811 | -2.40% | |
| 21Shares Pendle ETP | CH1495416997 | -3.30% | |
| 21Shares Bittensor ETP | CH1495416971 | -7.55% |
| Name | ISIN | Performance | |
|---|---|---|---|
| 21shares Canton Network ETP | CH1503127917 | 122.53% | |
| 21shares Hyperliquid Staking ETP | CH1471826029 | 105.04% | |
| 21shares Morpho ETP | CH1506167027 | 61.18% | |
| 21Shares NEAR Protocol Staking ETP | CH1162108893 | 22.34% | |
| 21Shares Toncoin Staking ETP | CH1297762812 | 10.41% | |
| 21Shares Injective Staking ETP | CH1360612134 | -0.88% | |
| 21Shares Jupiter ETP | CH1480821383 | -17.75% | |
| 21Shares Bittensor ETP | CH1495416971 | -26.72% | |
| 21Shares Dogecoin ETP | CH1431521033 | -34.32% | |
| 21Shares Cronos Staking ETP | CH1443364232 | -38.87% |
| Name | ISIN | Performance | |
|---|---|---|---|
| 21Shares Bitcoin Gold ETP | CH1146882308 | -1.52% | |
| 21Shares NEAR Protocol Staking ETP | CH1162108893 | -5.98% | |
| 21Shares Binance BNB ETP | CH0496454155 | -9.14% | |
| 21Shares Stellar ETP | CH1109575535 | -27.26% | |
| 21Shares Ethereum Core Staking ETP Acc | CH1209763130 | -33.64% | |
| 21Shares Cronos Staking ETP | CH1443364232 | -34.27% | |
| 21Shares Dogecoin ETP | CH1431521033 | -49.92% | |
| 21Shares Injective Staking ETP | CH1360612134 | -55.08% | |
| 21Shares Immutable ETP | CH1360612142 | -68.95% | |
| 21Shares Sui Staking ETP | CH1360612159 | -75.01% |
| Name | ISIN | Performance | |
|---|---|---|---|
| 21Shares XRP ETP | CH0454664043 | 124.51% | |
| 21Shares Stellar ETP | CH1109575535 | 85.04% | |
| 21Shares Bitcoin Gold ETP | CH1146882308 | 50.44% | |
| 21Shares Crypto Basket Equal Weight (HODLV) ETP | CH1135202161 | 12.82% | |
| 21Shares Binance BNB ETP | CH0496454155 | -4.61% |
Fundamentaldaten
| Valor | |
| ISIN | XS2399368062 |
| Emittent | Leverage Shares PLC |
| Aufgelegt in | Ireland |
| Auflagedatum | 10.12.2021 |
| Kategorie | Branchen: Biotechnologie |
| Währung | USD |
| Volumen | 727’071.13 |
| Depotbank | |
| Geschäftsjahresende | |
| Berichtsstand | 12.06.2026 |
Anlagepolitik
So investiert der LS ARK Genomic Revolution Tracker ETP Securities: The objective of the ETP is to track the ARKG Genomic Tracker Investment Strategy, (the 'Investment Strategy') which is designed to provide 1:1 exposure to the performance of ARK Genomic Revolution ETF (the “Reference Asset”), minus a fee. It invests all subscription proceeds and dividends received (net of taxes) directy into Reference Assets.
ETP Performance: LS ARK Genomic Revolution Tracker ETP Securities
| Performance 1 Jahr | 38.18 | |
| Performance 2 Jahre | 31.05 | |
| Performance 3 Jahre | -0.14 | |
| Performance 5 Jahre | - | |
| Performance 10 Jahre | - |